Alemtuzumab + PonesimodUnknown
Because of the characteristics and duration of alemtuzumab immune suppressive effects, initiating treatment with PONVORY after alemtuzumab is not recommended.
Source: FDA drug label - ponesimod
1 interaction on record
Because of the characteristics and duration of alemtuzumab immune suppressive effects, initiating treatment with PONVORY after alemtuzumab is not recommended.
Source: FDA drug label - ponesimod